These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 28516243

  • 1. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
    Wieser I, Wang C, Alberti-Violetti S, Lyons G, Tran C, Talpur R, Duvic M.
    Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E, Amitay-Laish I, Feinmesser M, Davidovici B, David M, Zvulunov A, Pavlotsky F, Yaniv I, Avrahami G, Ben-Amitai D.
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [Abstract] [Full Text] [Related]

  • 5. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience.
    Hodak E, Amitay-Laish I, Atzmony L, Prag-Naveh H, Yanichkin N, Barzilai A, Kershenovich R, Feinmesser M.
    J Am Acad Dermatol; 2016 Aug; 75(2):347-55. PubMed ID: 27245278
    [Abstract] [Full Text] [Related]

  • 6. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
    Marschalkó M, Erős N, Kontár O, Hidvégi B, Telek J, Hársing J, Jókai H, Bottlik G, Rajnai H, Szepesi Á, Matolcsy A, Kárpáti S, Csomor J.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
    [Abstract] [Full Text] [Related]

  • 7. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 8. The different faces of mycosis fungoides: results of a single-center study.
    Sidiropoulou P, Nikolaou V, Marinos L, Voudouri D, Komini E, Economidi A, Rigopoulos D, Stratigos A.
    Int J Dermatol; 2020 Mar 01; 59(3):314-320. PubMed ID: 31782525
    [Abstract] [Full Text] [Related]

  • 9. Immune privilege disruption in folliculotropic mycosis fungoides: investigation of major histocompatibility complex antigen expression.
    Deonizio JMD, Guitart J, Yazdan P, Mulinari-Brenner F, Sotto MN, Sanches JA.
    Int J Dermatol; 2018 Jun 01; 57(6):675-680. PubMed ID: 29603194
    [Abstract] [Full Text] [Related]

  • 10. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY, Pulitzer MP, Myskowski PL, Dusza SW, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2013 Sep 01; 69(3):366-74. PubMed ID: 23685027
    [Abstract] [Full Text] [Related]

  • 11. Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital.
    Kalay Yildizhan I, Sanli H, Akay BN, Uzundere C, Okcu Heper A.
    Dermatol Ther; 2020 Jul 01; 33(4):e13585. PubMed ID: 32410323
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 01; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 13. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT.
    Arch Dermatol; 1996 Nov 01; 132(11):1309-13. PubMed ID: 8915308
    [Abstract] [Full Text] [Related]

  • 14. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J.
    Arch Dermatol; 2008 Jun 01; 144(6):738-46. PubMed ID: 18559762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
    Kim YH, Chow S, Varghese A, Hoppe RT.
    Arch Dermatol; 1999 Jan 01; 135(1):26-32. PubMed ID: 9923777
    [Abstract] [Full Text] [Related]

  • 19. Follicular mycosis fungoides: variability of a rare entity.
    Roeschm A, Schleyer V, Landthaler M, Vogt T.
    Skinmed; 2005 Jan 01; 4(1):12-7. PubMed ID: 15654159
    [Abstract] [Full Text] [Related]

  • 20. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
    Lebowitz E, Geller S, Flores E, Pulitzer M, Horwitz S, Moskowitz A, Kheterpal M, Myskowski PL.
    J Eur Acad Dermatol Venereol; 2019 Jan 01; 33(1):108-114. PubMed ID: 30176169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.